XML 58 R10.htm IDEA: XBRL DOCUMENT

Investments

9 Months Ended

Sep. 30, 2015

Investments, All Other Investments [Abstract]

NOTE 5. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at September 30, 2015 and December 31, 2014 (in thousands):

AVAILABLE-FOR-SALE INVESTMENTS

September 30, 2015

(in thousands)

		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Asset-backed securities	$	2,515	$	1	$	—		$	2,516
Corporate notes and bonds		11,324		7		(7	)		11,324
Total	$	13,839	$	8	$	(7	)	$	13,840

December 31, 2014 (in thousands)
		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Asset-backed securities	$	141	$	—	$	—		$	141
Corporate notes and bonds		12,967		10		(3	)		12,974
Total	$	13,108	$	10	$	(3	)	$	13,115

The following table summarizes the maturities of the Company’s available-for-sale securities at September 30, 2015 and December 31, 2014 (in thousands):

AVAILABLE-FOR-SALE INVESTMENT MATURITIES (in thousands)
	September 30, 2015				December 31, 2014
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Due in less than 1 year	$	12,334	$	12,335	$	10,586	$	10,585
Due in 1-3 years		1,505		1,505		2,522		2,530
Total	$	13,839	$	13,840	$	13,108	$	13,115

Proceeds from sales of marketable securities (including principal paydowns) for the three-month periods ended September 30, 2015 and 2014 was $0 and $125,000, respectively, and for the nine-month periods ended September 30, 2015 and 2014 was $141,000 and $246,000, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no material gross realized gains or losses from sales of marketable securities for the three-month or nine-month periods ended September 30, 2015 and 2014.

No other-than-temporary impairments are recorded as no investments had a fair value that remained less than its cost for more than twelve months as of September 30, 2015 and there have been no other indicators of impairment. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.

Additional information regarding the fair value of our financial instruments is included in Note 3, Fair Value of Financial Statements.